Skip to Main Content

Tami Sullivan, PhD

Professor of Psychiatry; Co-Director, Division of Prevention and Community Research, Psychiatry; Co-Director, NIDA-funded T32 Training Program in Substance Use Prevention Research, Psychiatry; Director, Family Violence Research and Programs, Psychiatry; Associate Professor on Term, Social and Behavioral Sciences

Tami P. Sullivan, PhD, is Professor of Psychiatry (Psychology), Co-Director of the Division of Prevention and Community Research, Co-Director of the Postdoctoral Fellowship in Substance Use Prevention Research, and Director of Family Violence Research and Programs. Her program of research is centered on individual- and system-level factors that affect the wellbeing of victims of intimate partner violence (IPV), with specific attention to daily processes and micro-longitudinal designs (e.g., real-time assessment). At the individual level, Dr. Sullivan's work aims to advance understanding of the relationships among IPV and its highly prevalent negative outcomes such as posttraumatic stress, substance use, and sexual risk in an effort to develop preventive interventions that promote safety and resilience. At the systems-level, she conducts IPV research and evaluation within the criminal justice and other service systems (e.g., Health Care system, HIV service system). She studies the impact of the system?s response on victims? wellbeing including the ways in which it promotes or impedes victims? safety, recovery and resilience. Dr. Sullivan is a licensed psychologist with extensive clinical experience with victims and offenders of IPV, providing services in a range of settings from community programs, dual diagnosis programs, inpatient settings, and outpatient clinics to domestic violence shelters, transitional living programs, and community programs. Current projects include but are not limited to a focus on the role of firearm threat in the lives of women experiencing IPV, the ways in which IPV impacts the daily functioning of women living with HIV, a peer-led IPV support group intervention, a single-session, technology-facilitated hope-based intervention for women who have experienced IPV; and an effectiveness implementation study to promote retention in opioid treatment among women who experience IPV by targeting PTSD.